Singapore markets closed
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,071.63 +1.08 (+0.02%) Dow
38,460.92 -42.77 (-0.11%) Nasdaq
15,712.75 +16.11 (+0.10%) Bitcoin USD
63,843.68 -2,692.11 (-4.05%) CMC Crypto 200
1,358.12 -24.45 (-1.77%)
Lyell Immunopharma, Inc. (LYEL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.4400 |
| Open | 2.4200 |
| Bid | 2.2900 x 300 |
| Ask | 2.3200 x 1200 |
| Day's range | 2.2900 - 2.4800 |
| 52-week range | 1.3200 - 3.9700 |
| Volume | |
| Avg. volume | 922,206 |
| Market cap | 586.355M |
| Beta (5Y monthly) | -0.56 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) market cap decline of US$89m may not have as much of an impact on institutional owners after a year of 1.4% returns
Key Insights Institutions' substantial holdings in Lyell Immunopharma implies that they have significant influence over...
- Zacks
Lyell Immunopharma (LYEL) Is Up 28.45% in One Week: What You Should Know
Does Lyell Immunopharma (LYEL) have what it takes to be a top stock pick for momentum investors? Let's find out.
- GuruFocus.com
Lyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business Highlights
LYEL Advances Solid Tumor Cell Therapy Pipeline with Strong Cash Position into 2027
© 2024 Yahoo. All rights reserved.